Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) previously treated with platinum-based therapy.

Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum‐Based Therapy

The Oncologist ◽

10.1634/theoncologist.2016-0296 ◽

2016 ◽

Vol 21 (12) ◽

pp. 1416 ◽

Cited By ~ 7

Author(s):

Jean‐Pascal Machiels ◽

Aline Van Maanen ◽

Jean‐Marie Vandenbulcke ◽

Bertrand Filleul ◽

Emmanuel Seront ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Metastatic Squamous Cell Carcinoma ◽

Results of a phase II study evaluating monalizumab in combination with cetuximab in previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)

Annals of Oncology ◽

10.1093/annonc/mdy287.005 ◽

2018 ◽

Vol 29 ◽

pp. viii374 ◽

Cited By ~ 8

Author(s):

J. Fayette ◽

G. Lefebvre ◽

M.R. Posner ◽

J. Bauman ◽

S. Salas ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Metastatic Squamous Cell Carcinoma ◽

912P Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1322 ◽

2021 ◽

Vol 32 ◽

pp. S807-S808

Author(s):

V. Gruenwald ◽

U. Graeven ◽

P. Ivanyi ◽

A. Dietz ◽

D. Hahn ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)

Oral Oncology ◽

10.1016/j.oraloncology.2013.04.010 ◽

2013 ◽

Vol 49 (8) ◽

pp. 835-841 ◽

Cited By ~ 36

Author(s):

Sewanti Limaye ◽

Sarah Riley ◽

Sihai Zhao ◽

Anne O’Neill ◽

Marshall Posner ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Faculty Opinions recommendation of Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14264023.15777137 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Clinical Activity ◽

Molecular Response ◽

Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens

Oral Oncology ◽

10.1016/j.oraloncology.2010.08.013 ◽

2010 ◽

Vol 46 (11) ◽

pp. 818-821 ◽

Cited By ~ 8

Author(s):

Elena Massa ◽

Mariele Dessì ◽

Giulio Gaspardini ◽

Federica Saba ◽

Valeria Cherchi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

A phase II study of vinorelbine (VRL), cisplatin (CDDP) and 5-Fluorouracil (FU) in patients (PTS) with locally advanced recurrent, and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)

European Journal of Cancer ◽

10.1016/s0959-8049(99)81098-3 ◽

1999 ◽

Vol 35 ◽

pp. S176

Author(s):

V. Guillem ◽

M.A. Muñoz ◽

R. Yaya ◽

V. Soriano ◽

M.A. Climent ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽

Interim analysis of a single arm phase II study of adjuvant nivolumab after salvage resection in head and neck squamous cell carcinoma patients previously treated with definitive therapy

Annals of Oncology ◽

10.1093/annonc/mdz252.014 ◽

2019 ◽

Vol 30 ◽

pp. v455-v456

Author(s):

T. Wise-Draper ◽

S. Haque ◽

A. Steele ◽

S. Desai ◽

T. Harris ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Interim Analysis ◽

Phase Ii Study ◽

Salvage Resection ◽

Definitive Therapy ◽

A Non Platinum Regimen for the Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Region. Results From an Extended Phase II Study With Paclitaxel and Capecitabine

Frontiers in Oncology ◽

10.3389/fonc.2018.00243 ◽

2018 ◽

Vol 8 ◽

Author(s):

Jens K. D. Bentzen ◽

Claus Andrup Kristensen ◽

Marie Overgaard ◽

Carsten Rytter ◽

Kenneth Jensen ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Neck Region ◽

Extended Phase ◽

Head And Neck Region ◽

Abstract C166: Phase II study of cetuximab and lenalidomide in recurrent/metastatic squamous cell carcinoma of the head and neck.

10.1158/1535-7163.targ-13-c166 ◽

2013 ◽

Author(s):

Rodney J. Taylor ◽

Vassiliki Saloura ◽

Richard Wong ◽

Olga Goloubeva ◽

Lorna Silpino ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽